Cellares has launched the Cell Q platform, an automated quality control solution tailored for commercial-scale cell therapy manufacturing. Developed through strategic partnerships with Tecan, Cytek Biosciences, and others, Cell Q automates critical QC assays including vector copy number quantification, enhancing throughput to support up to 6,000 batches annually. This innovation addresses bottlenecks in manual testing, enabling scalable, reproducible, and efficient release testing workflows fundamental for broader commercialization of cell and gene therapies.